Tab Application Banner
  • Users Online: 787
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2020| December  | Volume 15 | Issue 6  
    Online since January 18, 2021

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Development of the myocite biobank: Cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis
R Naveen, Anamika Kumari Anuja, Mohit Kumar Rai, Vikas Agarwal, Latika Gupta
December 2020, 15(6):194-199
DOI:10.4103/injr.injr_95_20  
  5 711 56
Serum fatty acid-binding protein 3 levels differentiate active from inactive myositis and correlate with response to therapy
Latika Gupta, Sanjukta Majumder, Amita Aggarwal, Ramnath Misra, Able Lawrence
December 2020, 15(6):187-190
DOI:10.4103/injr.injr_57_20  
  1 604 69
REVIEW ARTICLES
The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus
John D Pauling, Sarah Skeoch, Julie J Paik
December 2020, 15(6):81-90
DOI:10.4103/injr.injr_136_20  
  1 676 133
CASE REPORT
Tacrolimus in refractory juvenile dermatomyositis: Case report and review of literature
Anand Prahalad Rao, Vinyasa Kolli, Indhuja Rajarathinam, Jyothi Raghuram
December 2020, 15(6):205-208
DOI:10.4103/injr.injr_128_20  
  - 463 62
LETTERS TO EDITOR
An atypical presentation of antisynthetase syndrome
Mayank Kapoor, Minakshi Dhar, Sukdev Manna
December 2020, 15(6):220-221
DOI:10.4103/injr.injr_134_20  
  - 621 60
Sociocultural challenges in patients with myositis and the unmet need for patient support groups: Perspectives from North India
Rudrarpan Chatterjee
December 2020, 15(6):222-224
DOI:10.4103/injr.injr_204_20  
  - 106 38
The muscle rap
Benzeeta Pinto, Sakir Ahmed
December 2020, 15(6):225-225
DOI:10.4103/injr.injr_49_20  
  - 120 36
We are in charge of treating myositis!
Ilke Coskun Benlidayi
December 2020, 15(6):226-226
DOI:10.4103/injr.injr_54_20  
  - 914 76
ORIGINAL ARTICLES
Combined case record forms for collating obstetric outcomes in rare rheumatic diseases
Rajat Kharbanda, R Naveen, Durga Prasanna Misra, Vikas Agarwal, Latika Gupta
December 2020, 15(6):191-193
DOI:10.4103/injr.injr_102_20  
  - 546 59
Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
Jeet Hemantkumar Patel, Lalit Duggal, Ved Chaturvedi, Neeraj Jain, Gurbir Bhandari, Mayank Gupta
December 2020, 15(6):200-204
DOI:10.4103/injr.injr_28_20  
  - 1,054 84
Is polymyositis a rare or over-diagnosed entity? A descriptive follow-up study of patients initially admitted in a tertiary center with the diagnosis of polymyositis
Pablo Arturo Olivo Pallo, Matheus Santos Rodrigues Silva, Fernando Henrique Carlos de Souza, Samuel Katsuyuki Shinjo
December 2020, 15(6):180-186
DOI:10.4103/injr.injr_111_20  
  - 466 49
PERSPECTIVES
Idiopathic inflammatory myopathies: Contributions from India
Anand Narayan Malaviya
December 2020, 15(6):209-216
DOI:10.4103/injr.injr_51_20  
  - 833 65
Conquering myositis, beyond remission
Amber OConnor, TG Sundaram
December 2020, 15(6):217-219
DOI:10.4103/injr.injr_179_20  
  - 70 19
PREFACE
Inflammatory myositis - Foray into the future
Neil McHugh, Latika Gupta
December 2020, 15(6):73-73
DOI:10.4103/0973-3698.238193  
  - 475 122
REVIEW ARTICLES
Bye-bye muscle biopsy, we have autoantibodies with us now
Victoria Riddell, Sarah L Tansley
December 2020, 15(6):74-80
DOI:10.4103/injr.injr_114_20  
  - 1,870 218
Juvenile dermatomyositis: Controversies and recent developments in management
Himanshi Chaudhary, Satish Kumar Loganathan, Surjit Singh
December 2020, 15(6):112-122
DOI:10.4103/injr.injr_107_20  
  - 934 105
Idiopathic inflammatory myopathy: From muscle biopsy to serology
Ritu Verma, Vimal Kumar Paliwal
December 2020, 15(6):123-130
DOI:10.4103/injr.injr_165_20  
  - 399 71
Cancer in myositis
Albert Selva-OCallaghan, Maria Terrones-Peinador, Joana Rita Marques-Soares, Albert Gil-Vila
December 2020, 15(6):131-136
DOI:10.4103/injr.injr_168_20  
  - 489 37
Statin-associated muscle disorders
Alan Xu, Vidya Limaye
December 2020, 15(6):137-144
DOI:10.4103/injr.injr_81_20  
  - 196 85
Sporadic inclusion body myositis in the rheumatology clinic
Fernando Henrique Carlos de Souza, Gustavo Luiz Behrens Pinto, Jean Marcos de Souza, Pablo Arturo Olivo Pallo, Leonardo Santos Hoff, Samuel Katsuyuki Shinjo
December 2020, 15(6):145-152
DOI:10.4103/injr.injr_80_20  
  - 863 76
Emerging therapeutics in idiopathic inflammatory myopathy
Shinji Sato
December 2020, 15(6):153-162
DOI:10.4103/injr.injr_124_20  
  - 592 73
The evolving spectrum of interstitial lung disease in myositis—Management pearls
Takahisa Gono
December 2020, 15(6):163-174
DOI:10.4103/injr.injr_118_20  
  - 469 70
Assistive devices: Regaining mobility in myositis
Samira Davalbhakta, Akshay Oswal, Sanat Phatak
December 2020, 15(6):175-179
DOI:10.4103/injr.injr_90_20  
  - 824 44
Picking interstitial lung disease out of the myositis haystack
Jennifer Hannah, Harsha Gunawardena
December 2020, 15(6):91-98
DOI:10.4103/injr.injr_189_20  
  - 703 110
Pathogenesis of muscle weakness in inflammatory myositis
Sai Kumar Dunga, TG Sundaram, Chengappa G Kavadichanda
December 2020, 15(6):99-111
DOI:10.4103/injr.injr_120_20  
  - 1,096 113